Larry K. Hampton
FDA investigator
Appears on 2 documents from 2017 to 2018, mostly at sites in South Carolina. Most often cites production record review (21 CFR 211.192).
- 2
- Documents on file
- 1.5
- Observations per 483
- 2017
- First seen
- 2018
- Most recent
What they cite most
From 3 observations- 21 CFR 211.192Production record review1
- 21 CFR 211.22Responsibilities of quality control unit1
- 21 CFR 211.28Personnel responsibilities1
Activity by year
2017: 1, 2018: 1
Where
South Carolina 2
Often inspects with
Is Larry K. Hampton coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2018-04-20 | 483 Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding CenterApr 20, 2018 · West Columbia, South Carolina | West Columbia, South Carolina | 1 | |
| 2017-12-15 | 483 Alcami Carolinas CorporationDec 15, 2017 · Charleston, South Carolina | Charleston, South Carolina | 2 |
About this profile
What does Larry K. Hampton inspect?
Larry K. Hampton appears on 2 documents on file covering 2 sites, mostly in South Carolina.
What do they cite most often?
21 CFR 211.192 (production record review), followed by 21 CFR 211.22 and 21 CFR 211.28.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Larry K. Hampton is dated Apr 20, 2018.